戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 n have other autoimmune disorders, including autoimmune thyroid disease.
2 female reproduction, and reduces the risk of autoimmune thyroid disease.
3 dies contributes to the skin changes seen in autoimmune thyroid disease.
4 ing 18q22 and 18p11, showed association with autoimmune thyroid disease.
5 omplex and AITD1, a susceptibility locus for autoimmune thyroid disease.
6 cular and renal anomalies, hypertension, and autoimmune thyroid disease.
7 re, ovarian failure, high-arched palate, and autoimmune thyroid disease.
8 econdary autoimmune adverse effects, such as autoimmune thyroid disease.
9 D4 T-cell counts were lower in patients with autoimmune thyroid disease.
10  to inflammation and edema in the setting of autoimmune thyroid disease.
11                          Subject 2 developed autoimmune thyroid disease 1.6 years after transplantati
12                                              Autoimmune thyroid disease (AITD) and pernicious anemia
13 N22 1858T variant also increased the risk of autoimmune thyroid disease (AITD) in the RA patients, wh
14                                              Autoimmune thyroid disease (AITD) is a common autoimmune
15  with germinal centers are often detected in autoimmune thyroid disease (AITD), but the mechanisms un
16                                              Autoimmune thyroid disease (AITD), including Graves' dis
17 endent cases of ankylosing spondylitis (AS), autoimmune thyroid disease (AITD), multiple sclerosis (M
18 sociation between type 1A diabetes (T1D) and autoimmune thyroid disease (AITD).
19 equence signatures conferred a high risk for autoimmune thyroid disease (AITD).
20  previously shown to be strongly linked with autoimmune thyroid disease (AITD).
21 some 18q12-q22 in 81 sib pairs affected with autoimmune thyroid disease (AITD).
22                                              Autoimmune thyroid diseases (AITD) affect 2-5% of the po
23                                              Autoimmune thyroid diseases (AITD) arise from complex in
24                                          The autoimmune thyroid diseases (AITD), Graves' disease and
25 fic HLA class II variant conferring risk for autoimmune thyroid diseases (AITD).
26                                              Autoimmune thyroid diseases (AITDs) are highly prevalent
27                                          The autoimmune thyroid diseases (AITDs) include two related
28                                          The autoimmune thyroid diseases (AITDs), comprising Graves d
29         This is one of very few models where autoimmune thyroid disease and hypothyroidism develop in
30 or for the concurrent autoimmune diseases of autoimmune thyroid disease and SLE.
31  in risk applies to each autoimmune disease, autoimmune thyroid disease (and Graves' disease in parti
32  celiac disease, inflammatory bowel disease, autoimmune thyroid disease, and juvenile rheumatoid arth
33        The TSHR is also a primary antigen in autoimmune thyroid disease, and some TSHR antibodies may
34 tis, Graves' disease, Hashimoto thyroiditis, autoimmune thyroid disease, and systemic lupus erythemat
35 rthritis (RA), systemic lupus erythematosus, autoimmune thyroid disease, and type 1 diabetes mellitus
36 rapy, pregnancy in the setting of underlying autoimmune thyroid disease, and with the use of certain
37 cially rheumatoid arthritis, celiac disease, autoimmune thyroid diseases, and type 1 diabetes.
38 ncomitant autoimmune disorders, particularly autoimmune thyroid disease, are common.
39 sulin-dependent diabetes mellitus (IDDM) and autoimmune thyroid disease (ATD), share genetic risk fac
40 zyme immunoassay on serum from patients with autoimmune thyroid disease (ATD).
41 o increases on TECs during development of an autoimmune thyroid disease characterized by TEC hyperpro
42 NaI)-supplemented water develop a slow onset autoimmune thyroid disease, characterized by thyrocyte e
43 ulin (Tg) are a prominent feature of the two autoimmune thyroid diseases, chronic lymphocytic (Hashim
44 iated with type 1 diabetes mellitus and with autoimmune thyroid disease, confirming the findings of o
45                   Graves' disease (GD) is an autoimmune thyroid disease defined by the production of
46 We have genotyped 77 affected sib-pairs with autoimmune thyroid disease for eight polymorphic markers
47                       Familial clustering of autoimmune thyroid diseases has led to studies of their
48 e 1 diabetes (T1D), multiple sclerosis (MS), autoimmune thyroid disease (Hashimoto thyroiditis or Gra
49 arious combinations of generalized vitiligo, autoimmune thyroid disease, latent autoimmune diabetes i
50 heumatoid arthritis, polymyalgia rheumatica, autoimmune thyroid disease, psoriasis, and all others.
51 us studies have indicated that patients with autoimmune thyroid disease recognize epitopes of Tg whic
52 igo and other autoimmune diseases, including autoimmune thyroid disease, rheumatoid arthritis, and ty
53                                Screening for autoimmune thyroid disease should be performed.
54 E patients (cohorts 1 and 3) with documented autoimmune thyroid disease, the T allele frequency was h
55 iseases, such as inflammatory bowel disease, autoimmune thyroid disease, type 1 diabetes mellitus (T1
56 cious anaemia, systemic lupus erythematosus, autoimmune thyroid disease, vitiligo, and myasthenia gra
57  clinical significance of the association of autoimmune thyroid disease with DTC is less clear.
58  with TgAb assay methods, the association of autoimmune thyroid disease with DTC, the prognostic sign